GGrantIndex
← Search

Cancer Control and Survivorship

$155,272P30FY2024CANIH

University Of California Los Angeles, Los Angeles CA

Investigators

Linked publications, trials & patents

Trial NCT07339085Trial NCT07276438Trial NCT07242365Trial NCT06650163Trial NCT06568016Trial NCT06113016Trial NCT05595499Trial NCT04205838Trial NCT04201873Trial NCT04185311Trial NCT04119024Trial NCT04106362Trial NCT04069923Trial NCT04069910Trial NCT04050215Trial NCT04007029Trial NCT03996850Trial NCT03970252Trial NCT03953157Trial NCT03904251Trial NCT03902951Trial NCT03892720Trial NCT03830918Trial NCT03825796Trial NCT03745690Trial NCT03732950Trial NCT03732352Trial NCT03672773Trial NCT03623854Trial NCT03618134Trial NCT03603223Trial NCT03601455Trial NCT03596710Trial NCT03582774Trial NCT03582475Trial NCT03541850Trial NCT03515577Trial NCT03506802Trial NCT03425461Trial NCT03411070Trial NCT03368547Trial NCT03319342Trial NCT03240861Trial NCT03202472Trial NCT03128619Trial NCT03025139Trial NCT03014804Trial NCT02940262Trial NCT02928510Trial NCT02925351Trial NCT02919332Trial NCT02902757Trial NCT02888301Trial NCT02881242Trial NCT02880020Trial NCT02879994Trial NCT02830165Trial NCT02816879Trial NCT02775292Trial NCT02756130Trial NCT02701153Trial NCT02688348Trial NCT02683200Trial NCT02672033Trial NCT02597894Trial NCT02575027Trial NCT02451865Trial NCT02336763Trial NCT02310594Trial NCT02296229Trial NCT02280161Trial NCT02263898Trial NCT02176902Trial NCT02070406Trial NCT02049593Trial NCT02048020Trial NCT02015559Trial NCT01912820Trial NCT01013285Trial NCT01005472Trial NCT00999557Trial NCT00998010Trial NCT00985192Trial NCT00955591Trial NCT00882765Trial NCT00880542Trial NCT00769470Trial NCT00706615Trial NCT00685516Trial NCT00616642Trial NCT00612066Trial NCT00601289Trial NCT00601094Trial NCT00521209Trial NCT00509431Trial NCT00471887Trial NCT00450567Trial NCT00444223Trial NCT00352001Trial NCT00349167

Abstract

CANCER CONTROL AND SURVIVORSHIP RESEARCH PROGRAM (CCS) ABSTRACT For over 25 years, the UCLA Jonsson Comprehensive Cancer Center (JCCC) has produced impactful research in cancer prevention and control, spanning the entire cancer control continuum. This work is based in the Cancer Control and Survivorship (CCS) Program, which has the breadth and depth of faculty expertise to tackle existing and emerging cancer control problems using approaches from genomics, machine learning, smarter cancer prevention and screening strategies, health outcomes research, and implementation science which can guide cancer care delivery from primary prevention through end-of-life settings and can inform health policy. There are 46 members in the CCS Program representing 16 departments spanning the Fielding School of Public Health, the David Geffen School of Medicine, and the College of Letters and Sciences. As of March 1, 2019, Program support was $26,487,925 in direct cost funding, of which $3,850,239 (15%) was from the NCI and $12,843,034 (48%) was peer-reviewed. Program research resulted in 1,127 publications between 2013-2018, of which 21% were intra-programmatic and 13% were inter-programmatic collaborations, with extensive use of the BASE shared resource. Also, 73% of total publications were inter-institutional collaborations, with 34% of the total in high-impact (IF ≥10, or field leading) journals. The CCS Program has three specific aims. Aim 1: To identify risk and protective factors for cancer as well as the most effective strategies for reducing cancer risk in the population. Aim 2: To determine the best methodologies for cancer screening and diagnosis and to identify the most effective strategies to increase uptake of cancer screening at the population level. Aim 3: To conduct research with findings that have the potential to reduce avoidable morbidity and mortality among patients with cancer and long-term survivors of cancer. CCS research is informed by, and highly responsive to, the cancer burden and needs of the JCCC catchment area, Los Angeles County (LAC). The county cancer burden is high, with large differences in cancer risk factors and cancer outcomes by ethnicity, gender, and socio-economic indicators. Thus, cross cutting themes that address health disparities and improvements in health outcomes permeate the research conducted by CCS investigators. Examples of impactful program research in the prior project period include: (1) Research showing very low rates of HPV vaccination for low income, ethnic minority adolescents in safety-net settings, resulting in multiple trials to improve vaccine uptake. (2) A study demonstrating the cost effectiveness of low-dose lung cancer CT screening that influenced the national dialog on lung cancer screening guidelines. (3) Findings that incidence rates for several childhood cancers among children of US born Latinas were higher than for children of immigrant Latinas, implicating lifestyle and environment during pregnancy. (4) A study in breast cancer survivors with severe insomnia showing that standard-of-care cognitive behavioral therapy-insomnia (CBT-I) or Tai Chi Chih (TCC) were both effective, but access to CBT-I therapists is limited, whereas TCC is widely accessible.

View original record on NIH RePORTER →